Top News

Eli Lilly signage on a pharmaceutical company building with a US flag above

INNOVATION

9 Jan 2026

The Race to Replace Needles With Pills Gets Smarter

AI-powered collaborations are speeding oral obesity and diabetes drugs, promising easier dosing and a faster path from discovery to market

MARKET TRENDS

22 Jan 2026

GLP-1 Drugs Get Cheaper and More Consumer-Friendly

Pre-filled GLP-1 injection pens used in obesity and metabolic disease treatment

REGULATORY

15 Jan 2026

FDA Reasserts Limits as GLP-1 Shortages Fade

Latest News

RESEARCH
27 Feb 2026
Can AI Crack the Code on Fibrosis?
INNOVATION
25 Feb 2026
AI Unlocks the Secret to Cell Entry
PARTNERSHIPS
24 Feb 2026
U.S. Peptide Groups Form GMP Alliance
INVESTMENT
23 Feb 2026
$305mn Bet on Peptides Signals Shift in Cancer

AI-Designed Peptide Enters Late-Stage Infection Trial

White pills and capsule with thermometer on dollar notes

INNOVATION

20 Feb 2026

Peptilogics advances zaloganan into Phase 2/3 with $120mn in funding to tackle biofilm-related joint infections

BioDuro-Sundia building exterior with company signage.

INSIGHTS

3 Aug 2025

AI Duo Supercharges Peptide Drug Discovery

BioDuro and Atombeat unite AI and automation to cut peptide drug timelines, fueling faster, smarter R&D breakthroughs.

Blue pill symbolizing oral peptide drug innovation.

RESEARCH

21 Jun 2025

A Needle-Free Future? This Biotech Thinks So

Sethera's tech aims to deliver peptide drugs by pill, cutting out injections and improving chronic care.

Blue smart pill symbolizing AI in drug innovation.

PARTNERSHIPS

15 Jun 2025

Can AI Crack the Code on Peptide Drugs?

TandemAI and Perpetual join forces to revolutionize peptide drug R&D, combining AI, lab automation, and expert leadership to speed bre...

Close-up of medical vials filled with injectable solution.

PARTNERSHIPS

12 Jun 2025

From Weekly to Monthly: Lilly’s Bold Injection Shift

Partnership with Sweden’s Camurus aims to reduce injection frequency and strengthen Lilly’s metabolic health portfolio

INVESTMENT

6 Jun 2025

AI Startup Secures $11M to Supercharge Cancer Drug Discovery

ProteinQure lands $11M to accelerate AI-designed peptide drugs, targeting cancer, brain, and kidney treatments with speed and precision.

REGULATORY

16 May 2025

New FDA Rules Are Reshaping the Peptide Industry

Upcoming policy change pushes peptide sector toward stricter compliance and formal drug approval pathways

7 8 9

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.